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Abstract
The green alga Volvox carteri exhibits a virtual absence of protein
synthesis in the dark, but begins synthesizing proteins necessary for
growth and development almost immediately after exposure to the light.
The regulation of protein synthesis in this system is known to be
translational since extracts prepared in the dark have identical pools and
quantities of mRNA as extracts prepared in the light (Kirk and Kirk, 1983).
Exploration of the mechanism of translational regulation has lead us to
consider the importance of signal transduction pathways. By using a
variety of commercially available drugs that affect specific components of
known signaling pathways, we have been able to propose a preliminary
model for a signal transduction pathway which regulates translation in
Volvox via a photoreceptor which responds to light and the second
messenger, cyclic.guanosine monophoshate (cGMP).
for cGMP have confirmed this model.
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In addition, assays

Introduction

The freshwater, multicellular, colonial green alga Volvox carleri has long been
considered a boon to the fields of evolutionary and developmental biology. An extensive
range of complexily exists within the "volvocine lineage," which putatively defines a
directed evolution of algae beginning with the unicellular, biflagellate Chlamydomonas.

spanning a wide range of species with a trend of increasing numbers of uniquely organized

Chlamydomonas-like cells, and reaching an apex with Volvox, which displays a distinct
level of cellular differentiation and a clear division of labor between only two cell types
(Schmitt et al.. 1992; Kirk and Harper, 1986). The fIrst of these cell types is the gonidium..
or reproductive cell, of which there are approximately 12-16 in a typical growing and
dividing organism in a favorable environment. These gonidia are surrounded by a roughly
spherical shell of about 2000 somatic, or vegetative, cells in an adult Volvox. These
somatic cells are biflagellate in nature, and thus morphologically resemble their
evolutionary ancestor, Chlamydomonas (Schmin et aI., 1992; Kirk and Harper, 1986). The
somatic cells differ sharply not only in function and biochemical composition (as shown by
the differences in mRNA pools between cell types that Lai-Wa Tam and coworkers detected
in 1991), but also in size and structure from the relatively large and morphologically
symmetrical gonidia This dichotomy of celllypes makes Volvox an ideal system for
determining and understanding the regulation of cellt;tlar differentiation and development,
and a useful model for more complex systems.
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as a pre-inversion embryo within an adult Volvox (Kirk and Harper, 1986; Tam et al.,
1991; Schmitt et aL, 1992).
A few hours after the Volvox enter the first of two eight hour dark periods, the
next stage of development, "inversion," occurs. During this stage, a hole, or phialopore,
appears in one end of each embryo. The embryo loses its spherical shape as it undergoes
inversion, a process where the embryo is essentially turned "inside-out" as the intact pole
of the spherical embryo moves through the phialopore, and an invened sphere eventually
reforms. The somatic cells now envelope a dense, glycoprotein-rich extracellular matrix
and the 16 reproductive cells which will soon begin a new cycle of cleavage. These newly
inverted strucrnres are now classified as "juveniles." At the start of the second 24-hour
period, when the Volvox are again exposed to light, the juveniles grow and mature until
they are ready to break free from their "mom" and begin their own life cycle. This stage,
appropriately termed "hatching" averages a 12-16-fold increase in the number of organisms
in a culture (depending on the number of gonidia originally within each organism) and is
followed by the senescence of the "mother" organism, or essentially the dissolution of the
somatic shell (Kirk and Harper, 1986; Tam et al., 1991; Schmin et ai., 1992). By
maintaining the Volvox in a laboratory setting with timed light/dark periods and a specific
nuttient media, synchronous cultures can be isolated and maintained for study.

Protein Synthesis.
One of the most intriguing observations regarding Volvox caneri is its light
dependent protein synthesis (Kirk and Kirk, 1983; Girardin, unpublished observations).
While protein synthesis is abundant during both light periods of the asexual life cycle, a
rapid decline in the amount of proteins synthesized is observed as soon as the Volvox enter
the dark.. In general, the initiation of protein synthesis in the light and the decline of protein
synthesis in the dark describes the pattern of most (if not all) proteins within Volvox. This
panern seems puzzling since proteins are necessary for growth, division, and
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differentiation, and Volvox continue their development, in at least the fIrst dark period, as
they undergo inversion. However, because all proteins are not utilized in the same quantity
nor at the same time, there must exist at least one mechanism of regulation for protein
synthesis. In order to consider potential sites of the regulation of protein synthesis, we
must first look at how proteins are made within eukaryotes.
The process of protein synthesis begins with transcription, the interpretation of the
DNA-encoded genetic information of an organism as a complementary strand of mRNA.
Transcription occurs within the nucleus of a cell, and so the new strand of mRNA must be
transported to the cytosol where the ribosomes, or the functional unilS of protein synthesis,
are located before translation can occur (Lodish et a1., 1995). Translation can be
subdivided into three phases: initiation) elongation, and termination (Hershey, 1991). A
prerequisite for the initiation of translation is the presence of the energy source GTP and
certain initiation factors, or proteins which directly bind or indirectly facilitate binding
between mRNA and ribosomes and subsequent recognition of a start codon (AUG). Two
initiation factors, eIF-4F and eIF-2, are known to be involved in regulating protein
synthesis in many mammalian systems through a mechanism of reversible
phosphorylation) which prohibits the initiation of translation (Hershey, 1991). Though

many of the same initiation factors have been identified in plants, specifically wheat germ,
it is unclear at this time if these initiation factors have the same importance and are
controlled by the same mechanisms in plants as they are in mammals (Janaki et aI., 1995;
Shaikhin et al., 1992). During the second phase of translation, elongation, the ribosomes
pair appropriate molecules of tRNA according to their three base sequence (anti-codon), to
the complementary three base mRNA sequence, or codon. Each tRNA molecule has a
specific amino acid associated with it, and in a cyclic manner, amino acids are joined one at
a time by peptide bonds, forming a polypeptide. Termination of translation occurs when a
stop codon is recognized, and the nascent polypeptide or protein is released (Hershey,
1991).
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This multi-step description of protein synthesis provides two obvious places for

regulation: transcription and translation. By comparing extracts that have been prepared
from Volvox in the dark for a minimum of 12 hours with extracts prepared from VoLvox
that have been exposed to the light for one hour after an extended dark period (also of at
least 12 hours), one can examine the issue of control. As stated previously, VoLvox carteri
abort protein synthesis in the dark and initiate protein synthesis in the light. Similarly, the
amount of protein synthesized de novo during a cenain time period (at least one hour) is
much greater in the light samples than in the dark samples.

It has been previously shown

(Kirk and Kirk, 1985; Kirk and Kirk, 1986), however, that equivalent levels ofmRNA
transcripts appear in extracts of Volvox that have been exposed to either the light or to the
dark. This suggests that control of protein synthesis is exerted post-transcriptionally, and
that light somehow acts as a necessary trigger to tum on translation.

SignaL Transduction.
The mechanism by which light acts to initiate protein synthesis is a major focal
point of Volvox research. In the study described in this paper, we have hypothesized that a
signal transduction pathway involving a G-protein-linked photoreceptor may mediate
protein synthesis in Volvox. Though G-protein signal transduction pathways can vary
extensively, there are certain components which are common to all pathways of this type. A
general G-protein pathway is described as follows (Lodish et aI., 1995). An external
stimulus fIrst initiates a change which affects the cell-surface-linked receptor. This receptor
is associated with a G-protein that can act as a stimulatory or an inhibitory G-protein and is

generally composed of multiple subunits. One of the subunits, the Go cycles between an
active and an inactive form by binding a diphosphate nucleotide [guanosine diphosphate
(GDP) or adenosine diphosphate (ADP)] in the inactive form and a triphosphate nucleotide
[guanosine triphosphate (GTP) or adenosine triphosphate) in the active form. The GTP
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bound G is able to dissociate from the other G-protein subunits and activate an effector
Q

protein (often an adenylate or guanylate cyclase). It is the action of the effector protein
which hydrolyzes the oiphosphate nucleotide to its respective cyclic roonophosphate form
[cyclic-guanosine monophosphate (cGMP) or cyclic-adenosine roonophosphate (cAMP)].
This action produces consequential changes in the concentrations of the intracellular
nucleotide phosphate pool since both cGMP and cAMP can act as second messengers that
pennit signal amplification, trigger a cascade of intracellular changes including a series of
phosphorylation/dephosphorylation reactions, and ultimately, initiate or inhibit protein
synthesis.
A specific model signal transduction pathway is that of mammalian vision, which
operates via the photoreceptor rhodopsin and the G-protein transducin to increase the
concentration of the second messenger cGMP and activate a cGMP-dependent
phosphodiesterase (which can degrade cGMP when activated by an abundance of cGMP) .
A cascade of events follows, including reversible phosphorylation, ultimately enabling the
state of hyperpolarization which is necessary for sight to occur (Khorana, 1992). It is
possible that the light-dependent signal transduction pathway responsible for translational
control in Volvox carteri may have similar stimuli, phororeceptors, G-proteins. and second
messengers as this vision pathway, though the pathways have notable differences in their
kinetics: vision results in a rapid, shon-term response, while the regulation of prOlein
synthesis in Volvox is a slow, long-tenn response.

Photoreception.
One specific characteristic of each somatic cell of Volvox is the presence of an
eyespot that appears red due to the pigment rhodopsin (Van Den Hoek et al., 1995). The
eyespot can be easily distinguished from the green, chlorophyll-laden body of the
vegetative cell (Bold and Wynne, 1985). Rhodopsin is a retinal-<::ontaining protein
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photoreceptor (Hegemann and Harz, 1993) and is known as lhe "universal visual pigment
of animals" (Van Den Hoek et aI., 1995). However, rhodopsin has also been found to
exist and function as a photoreceptor in some members of the Kingdom Bacteria., as well as
other members of the volvocine algae (Khorana, 1992; VanDen Hoek et aI., 1995).
Multiple spectroscopic studies in Chlamydomonas have shown that the phototactic behavior
of Chlamydomonas may be directed by the photoreceplOr character of rhodopsin
(Hegemann and Harz, 1993). For this reason, rhodopsin is also a good candidate for the
photoreceptor in Volvox which intercepts the external stimulus light and results in the
regulation of protein synthesis.
The srudies described in the remainder of this paper were instituted in an effort to
investigate potential signal transduction pathways controlling light-dependent translational
control in Volvox carteri. An effective way to srudy signal transduction pathways is by
inhibiting a pathway at different points and observing changes in the flnal outcome of the
pathway (in this case, protein synthesis). This method of in vivo manipulation with drugs
has previously been proven effective in Volvox (Gilles et ai., 1985; Jaenicke, 1991)
during the investigation of a cAMP-dependent pheromone induction of sexual Volvox. In
addition, in Chlamydomonas. a blue-light-dependent signal transduction pathway was
srudied by similar manipulations with various drugs that were known to activate or inhibit
essential components of many signal transduction pathways (pan et ai., 1996). Likewise,

in the present study, various drugs which affect components of signal transduction
pathways were administered to Volvox exposed to the light or the dark. in an anempt to
eluci&le the specific pathway controlling protein synthesis. In addition, we looked at the
effects of some of these drugs during the two transition periods between light and dark.
The results obtained allow us to propose a signal transduction pathway regulating protein
synthesis that involves a cGMP intermediate. Assays of cOMP concentrations at various
times during the Volvox life cycle provide evidence supporting this model.
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Materials and Methods

Drugs.
All drugs were purchased from CALBIOC~. 3-Isobutyl-1-methylxanthine
(IBMX), K-252a. 8-methoxymethyl-3- isoburyl-l-methylxanthine (MM-IBMX), MY-5445
[1-(3-Chlorophenylamino)-4-phenylphthalozine], Quazinone, RO-20-1724 [4-(3-butoxy-4
methoxybenzyl)-2-imidazolidinone], SQ 22536 [9-(terrahydro-2' -furyl)adenine], and
zaprinast {1,4-dihydro-5-(2-propoxypheny1)-7H -I ,23 -triazolo[4,5-<1.]pyridimine-7-one] )
were all prepared in DMSO in I roM stock concentrations. Dipyridamole and KT5823 were
also prepared in DMSO, but at 100 mM and 0.1 mM concentrations, respectively. 8
Bromo-cyclic-adenosine monophosphate, 8-bromo-cyclic-guanosine monophosphate,
dibutyryl-cyclic-guanosine monophosphate, and isoproterenol were all prepared in distilled
water at concentrations of 1 roM. The sodium sait of okadaic acid was also prepared in
distilled water, but at a 0.1 roM concentration. LY 83583 [6-anilino-5,8-quinolinequinone]
was prepared at a concentration of 1 mM in elhanol.

Isolation of Conidia.
Volvox were ftltered in a laminar flow hood using a sterile Gelman Sciences 300
ml ftltration device, and a 30 JlID nylon mesh futer. Depending on the number of flasks
being used, either a 15-ml or a 4O-ml Dounce homogenizer was used and filled with to ml
or 35 m1 of the essential nutrient media. Standard Volvox Media (SVM), respectively.

Volvox collected on the ftlter were rinsed into the homogenizer and physically
homogenized with seven srrokes of the loose ("A") Dounce pestle. The mixrure was then
transferred to either a 15-ml or 50-ml sterile Fisher centrifuge tube and 0.7 ml of Percoll
per 10 ml Volvox mixture was added. After inverting the tube several times to mix, the
sample was centrifuged for 5 minutes at room temperature at about 1500 rpm in a Fisher
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Scientific Centrific™ Centrifuge, and the supernatant was discarded, leaving the pellet for
res uspenslOD.

Toxicity Tests.
Prior to use in assays for protein synthesis determination, each drug and solvent
was tested for its generallOxicity to Volvox in order to determine appropriate
concentrations of drugs to be used during each assay. One milliliter of isolated gonima in
SVM was added to each well of a 24-well tissue culture plate, and various amounts of each
of the aforementioned drugs, and DMSO and ethanol alone, were added to separate wells
until a concentration could be found that did not seriously alter the organisms' color, size,
motility. morphology, or development in a period of two hours or less as compared to
controls. Concentrations that severely disturbed one or more of these properties (i.e. whole
organisms became non-motile and brown, white, shrunken, dissociated., and/or bad
shrunken or darkened reproductive cells) were considered ''toxic'' for reasons other than
their potential ability to inhibit protein synthesis, and were decreased until the majority of

Volvox in a well were found to be unaffected, but were severely affected at the next highest
concentration of the same drug. This "unaffected concentration" was considered
appropriate for use in further assays.

Measurements ofProtein Synthesis:
Preparation of Volvox. Two flasks of Volvox carteri were prepared one day prior to
assaying for protein synthesis, one for exposure to light and one to remain in the dark until
after sonication of the organisms. Preparation included isolation of the gonidia from
asexual Volvox in the first 24-hours of their life cycle (preferably during cleavage, but
never before), resuspension in a 500-ml flask of fresh, sterile SVM and covering each flask
with heavy duty aluminum foil after entering the dark period, and fmally returning the
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flasks to a 32°C bath. The next day, both flasks of juveniles were harvested by ftltration in
a Gelman Sciences 300-ml ftlter device using a 30 JlIl1 ftlter and rinsed and resuspended in
an appropriate amount of sulfur-free SVM (SF-SVM) depending on the number of assay
tubes to be used (appropriate volume equals 1.0 mlItube). The Volvox were resuspended

in a Petri dish, and 1 ml of the Volvo.xlSF-SVM mixture was aliquoted to each Fisherbrand
12 x 75 mm polypropylene test tube. Manipulations of one flask of Volvox (the "dark"
sample) were performed in the dark, without exposure to light. while the other sample (the
"light" sample) was prepared in the presence of normal fluorescent lighting. The dark
samples were covered with aluminum foil and left in the dark for approximately one hour,
while the light samples remained uncovered and were exposed to the light. Both sets of
samples were returned to the water bath during this time. After one hour in this sulfur
starved state, approximately 2 J..lCi of 3SS~SOJ (lCN) and an appropriate drug were
added to experimental samples, while only 21J,Ci 3SS~SOJ per tube was added to control
samples.

Measurements of protein synthesis inhibition. As controls, at least one dark sample and no
drugs were added to at least one light sample per assay. Experimental samples were
prepared as "light" samples, and after drug and label addition, they remained in a water
bath exposed to light for one additional hour before reactions were stopped by putting tubes
on ice and adding 4 rnl of ice cold SVM to each rube. Other srudies of drugs' inhibitory
abilities were done by using "dark" samples. but then exposing these to the light after drug
and label addition.

Measurements ojprotein synthesis activation. Initial assays of this type were done using
"dark" samples in addition to dark and light controls. Samples were kept in the dark for an
additional hour after drug and label addition before reactions were stopped as described
above. Later assays of this type were done by using "light"
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samp~es, but

after drug and

label addition, these samples were exposed to the dark for one hour. Assays of this later
type also yielded information about the transition state as the organisms undergo the light

dark transition.
Concentration Curves.

In an attempt to characterize the nature of the drugs that successfully inhibited
translation, and also to provide information to aid future studies to discover mutanlS
resistant to these drugs, drug concentration dependence was examined. A range of
concentrations between 0 and 2OO).IM for 8-brorno-cGMP, and between 0 and 20

J.lM for

MY-5445 and Zaprinast were added along wiLh the radioactive label to "light" samples, and
reactions were stopped after one hour in the light. Irmnediately after stopping the reactions,
samples from each concentration tube were taken for microscopic analysis of the
morphology and motility of the organisms.

Time Effect of 8-bromo-cGMP.

In order to confmn the effectiveness of the drugs over the experimental time (one
hour), the level of protein synthesis was measured over time. A constant concentration of
100 J..LM 8-bromo-cGMP was added with the radioisotope to "light" Volvox samples. The
reactions were stopped as described above 5, 15,30,45,60, and 90 minutes after time of
drug addition.

Quantification of Protein Synthesis:
Labeled extract preparation. After reactions were SlOPped, samples were uniformly

suspended by inversion and vacuum filtered using 0.45 ).1M nylon MAGNA-R membranes
(Micron Separations Inc.) in a Fisherbrand 15-ml glass ftltration device. Samples were

rinsed with SVM, resuspended in 1 ml of SVM in nllcrocentrifuge tubes, and put on ice in
the dark until all samples were ftltered. Tubes were shaken to free as many Volvox as
possible from the nitrocellulose membranes, and then centrifuged briefly in order to pellet
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the Volvox. Membranes were removed at this time, and Volvox were sonicated 3 times for
12-15 seconds each time, keeping tubes on ice between sonications. After removing 50 ~
each for TCA precipil.ation. samples were either frozen at -20°C or kept on ice (briefly) until
protein determination using the BioRad Standard, Microassay, and/or Standard procedure
for microtiter 96-well plates depending on the amount of protein per sample (Bio-Rad
Laboratories, LIT -33).

TeA precipitation. Fifty

~

of each of the above extracts was added to 1 rnJ 5%

lrichloroacetic acid (TCA) in microcenlrifuge tubes. Samples were boiled 5 minutes and
put on ice for approximately one hour. After incubation, samples were centrifuged briefly
to remove condensation from cap and pipened onto Fisherbrand Glass Fiber Filter Circles
G6 in a Stainless Steel Filtration Device for vacuum filtration. Samples were rinsed with
5% TCA, and ftllers were dried and put in 7-ml scintillation vials with 5-ml Econosafe
Scintillation Auid. Radioactivity was counted by liquid scintillation using the Beckman
LS3801.

cGMP Assay.
cGMP was assayed using an EUSA kit (Neogen Corporation, Lex.ington, KY).
Initial assays utili zed Volvox extracts prepared from Volvox exposed to the light for one
hour or remaining in the dark for 18 - 24 hours. Additional experiments monitored
changes in cGMP concentrations that occurred as freshly isolated, cleaving gonidia went

from being exposed to light in their normalligbt/dark cycle to remaining in the dark for an
extended period of time. Extracts were prepared at the end of the light period. immediately
after the dark period began, and 1,2,4,6, 12, and 20 hours after the dark period began.
Extracts were prepared in this case by harvesting the gonidia either in the light or in the
dark using a 30 J.1ID f.tlter in aGelman Sciences filtration device. Gonidia were
resuspended in PBS pH 7.5 and pelleted by centrifugation. Supernatant was removed
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until the remaining volume totaled 1 mt and samples were sonicated 5 times for 10 seconds
each. Samples were centrifuged at 14,000 rpm in a table top EppendorfiM Centrifuge for
one minute to remove any remaining whole gonidia 100-400 ~ were frozen at -lO°C for
protein determination at a later time, and the remainder of each sample was boiled for 4
minutes for deproteinization. Samples were centrifuged 10 minutes at 14,000 rpm, and
supernatant was collected and used immediately in assay or frozen at -20 o e for later use.
Concentrated samples or dilutions in PBS pH 7.5 from 1: 1 to 1: 19 were used in cGMP
assays.

Cakulations.
Results of protein synthesis were analyzed using Microsoft Excel version 5.0 by
subtracting the instrument blank from the total counts per minute (cpm) per sample,
determining cpm/J.Ll. and normalizing for the amount of protein per ~.
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Results

The results of the toxicity test are shown in Table 1. In addition to this information,

Volvox were able to tolerate pure ethanol and dimethylsulfoxide (DMSO) in concentrations
up to 5% and 10%. respectively (data not shown). These "effective concentrations" were
used in subsequent assays. with the exception of the concentration studies. which were
performed using wider ranges of concentrations, above and below the detennined effective
concentration. Concentrations higher than the effective concentrations listed in Table I
caused immotility in addition to dissociation of somatic cell sheath, discolored (brown,
white, or lranSlucent) cells. shrunken organisms. shrunken gonidia, arrested development
prior to inversion, enlarged somatic cells, and/or irregular distributions of somatic cells,
while concentrations lower than the effective concentration had no visible effects on DOnnal
motility or morphology.
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Table 1. A classification of the drugs used (based on their known activity
in other systems) and their effective concentrations. Abbreviations: PK-A
= cAMP-dependent protein kinase; PK-G = cGMP-dependent protein
kinase; PDE = phosphodiesterase; CaM = Calmodulin; AC = adenylate
cyclase; GC = guanylate cyclase (CALBIOCHEM~, 1996/97).

CLASS OF DRUG

DRUG

SOLVENT

B-Adrenergic Agornst

Isoproterenol

Water

100

PK-A Activator

8-bromo-cAMP

Water

100

PK-G Activator

8-bromo-cGMP

Water

100

Dibutyryl-eGMP '

Water

CONCENTRATION

;

100

mrvrx

DMSO

5

cAMP-specific

R0-20-1724

DMSO

0.5

cGMP-specific

Dipyridamole

DMSO

10

MY-5445

DMSO

0.5

Quazinone

DMSO

0.5

zaprinast

DMSO

1.0

MM-IBMX

DMSO

5

General PK Inhibitor

K-252a

DMSO

5

PK-G specific

KT5823

OMS0

0.05

AC Inhibitor

SQ 22536

DMSO

5

GC Inhibitor

LY 83583

Ethanol

1

Okadaic acid,

Water

5

PDE Inhibitor

CaM-specific

Phosphatase Inhibitor

(~M)

Sodium Salt

Results from the experiments measuring protein synthesis in variable conditions of
light and dark exposure are displayed in figures 2, 3, 4, and 5. Figure 2 illustrates that
though nearly all of the drugs tested revealed some inhibitory effect (30% or less), we were
able to frnd only three drugs which consistently reduced the amount of protein synthesis by
more than 60% in Volvox which were kept in the light throughout the experiment: MY

5445, zaprinast, and 8-bromo-cGMP. L Y83583 also showed some ability to inhibit
protein synthesis when exposed to light before and after drug addition, however, the
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results which we obtained using this drug varied greatly among experiments. In fact, we
also observed activation of protein synthesis in Volvox by LY83583 in the dark (figure 3).
Other than the inconsistencies observed with LY83583, we did not find evidence of
significant activation of protein synthesis in Volvox which remained in the dark throughout
the experiment (figure 3). Similarly, in figures 4 and 5, there was no indication of
significant activation of protein synthesis by any drug when Volvox were either maintained
in the dark until after drug and label addition or when Volvox were exposed first to the light

and then the dark.
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Figure 4. Effects of various drugs on protein synthesis in Volvox carleri
kept in the dark until the addition of drug and radioactive label, at which
time, samples were exposed to the light.
It is possible, however, to see inhibition of protein synthesis by KT5823 and K-252a in
figure 4 where Volvox were kept in the dark before drugs and label were added, but were
then exposed to the light (figure 4). It should be noted however, that inhibition by these
drugs could not be seen in figure 2 when Volvox remained in the light both before and after
drug and label addition.

23

20
~

'iii

10

.t::.
C

0

~

~

~

c _-10

,- 0
~

I.

-Q -·20
'
l:
I. Q

eC
0
l)

0•
e.Q.

~~
•
CD

(I)

~

an

~

Q"t"I-30

.: E
IlJ

e·40

u ....

c

IlJ
I.

~

:a
~

-50 
-60 

-70

-80

Figure 5. Effects of various drugs on protein synthesis in Volvox carteri
exposed to the light until the addition of drug and radioactive label, at
which time, samples were kept in the dark.
The concentration curves of both MY-5445 and 8-bromo cGMP (figures 6 and 7)
show a clear correlation between lhe amount of drug used and the extent of the inhibition of
protein synthesis. For both drugs, the trend is for an increased level of protein synthesis
inhibition with an increase in drug concentration. For 8-brom()-cGMP, a maxirnallevel of
inhibition is obtained near concentrations of

150~, though

a basal level of translation still

exists above thal of dark control samples (figure 6). In MY -5445 however, 10

~

concenrrations show maximum inhibition and this level of inhibition is comparable to the
level of protein synthesis observed in the dark control samples (figure 7). K l values (lhe
concentration at which inhibition is 50% of lhe maximum protein synthesis) are
approximately 60 ~ for 8-bromo-cGMP and
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Figure 6. The dependence of protein synthesis in Volvox carteri in the
presence of light on the concentration of the phosphodiesterase resistant
cGMP analog, 8-bromo-cGMP.
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Figure 7. The dependence of protein synthesis in Volvox carteri in the
presence of light on the concentration of the cGMP-specific
phosphodiesterase inhibitor, MY -5445.

The results of the time-dependent effect of 8-bromo-cGMP (figure 8) revealed that
8-bromo--cGMP began to affect translational activity between 5 and 15 rninUleS after time of
drug addition to Volvox in the light. After the initiation of the drug's activity, the level of
protein synthesis in the experimental sample closely mimicked that of the dark control,
though the slight increase in the amount of protein synthesis observed between 45 and 60
minutes in the two inhibited samples was greater for the experimental sample than for the
dark control.
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Figure 8. The effect of a constant concentration of 8-bromo-cGMP on
translation in Volvox carteri in the presence of light over a period of 90
minutes after the addition of drug and radioisotope label. Dark and Light
controls are included for comparison.
cGMP assays showed nearly 3 times more cGMP in "dark" Volvox extracts than in

light Volvox extracts, with a mean value (n=3) of 24.6 ng cGMP/rog total protein in the dark
and a mean value (n=3) of 9.32 ng cGMP/mg total protein in the light. In addition. the
amount of cGMP in Volvox increased with the amount of time spent in the dark, and there
was more cGMP after 20 hours in the dark than at any other time. The plot of cGMP
concentration versus time, however, did not reveal a clear trend (figure 9).
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Discussion

The drugs that were capable of inhibiting protein synthetic activity in Volvox carleri
fall into three major categories: cGMP analog, cGMP-specific phosphodiesterase
inhibitors, and protein kinase inhibitors. We will consider the implications of each of these
separately.
By adding the ceU·perrneable cGMP analog 8-bromo-cGMP (which is more
resistant to cGMP phosphodiesterases than nonna! cGMP and also has the ability to
activate protein kinase G) the cytosolic concentration of cGMP has effectively been
increased. If an increase in the cytosolic concentration of cGMP affectS the amount of
protein synthesis in the light, but not in the dark, we can postulate that under nonnal
(without exogenous drugs) conditions there are low levels of cGMP, and that an increase in
this concentration causes protein synthesis to be inhibited. On the other hand, if the levels
of cGMP are already high in the dark, then adding more in the form of an analog will have
no observable effect on the protein synthetic activity. If we imagine a model in which the
presence of cOMP is needed to tum off protein synthesis by binding to and activating
another enzyme, perhaps a phosphatase, then only a threshold level of cGMP would be

required A model of low levels of cytosolic cGMP in Volvox in the presence of light that
are somehow increased during the transition from light to dark would therefore agree with
the observed results thus far.
When MY-5445 and Zaprinast, inhibitors of cGMP-specific phosphodiesterases,
were added to Volvox in the presence of light, we again observed decreased protein
synthesis. Phosphodiesterases act to break down cyclic nucleotides in the cytosol. By
inhibiting the action of cOMP-specific phosphodiesterases, we are again causing an
effective increase in the amount of cGMP in the cytosoL The results show more than 60%
inhibition of protein synthesis in Volvox exposed to the light throughout the experiment in
the presence of both MY-5445 and zaprinast (figure 2). In addition, there was nearly
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100% inhibition of protein synthesis in Volvox which were not exposed to the light until
after drug addition (figure 4). We postulate a situation in which high levels of cGMP inhibit
protein synthesis. These results are in complete agreement with those obtained using 8
bromo-cGMP.
Finally, two protein kinase inhibitors, KT5823 specific to protein kinase G and K
252a (a general protein kinase inhibitor) were found to inhibit protein synthesis. Because
these two drugs did not inhibit protein synthesis in the same experimental conditions in
which the phosphodiesterase inhibitors or the cGMP analog did (light before and after drug
addition), but only inhibited translation when the Volvox were kept in the dark before drug
addition and were exposed to light afterwards, these results must be interpreted differently.
Protein kinases are common components of signal transduction pathways in which they are
activated by cyclic nucleotides, and then go on to phosphorylate other enzymes in the
cascade. Applying this to our model, we would expect that in the dark (high [cGMPD
phosphorylation would occur, which would have to inactivate protein synthesis. By
inhibiting this kinase in Volvox in' the dark. however, we would expect an absence of
phosphorylation and an activation of protein synthesis. Since we did not observe this
activation, we have looked toward a model of a cGMP-dependent protein phosphatase.
Phosphatases normally function to dephosphorylate, and thus have an antagonistic role
with regard to kina.ses. In this model, we would expect active dephosphorylation by a
cGMP activated phosphatase to occur in the absence of light, which would ultimately result
the inhibition of protein synthesis. If a situation of phosphorylation persisted, then
translation would be perpetuated. If a protein kinase were then inhibited in the light, the
equilibrium would shift toward a state of dephosphorylation, which would result in the
inhibition of protein synthesis. Because this state of dephosphorylation is not dependent
upon the activity of a phosphatase, but merely a lack of activity of a kinase, we must realize
that if the Volvox were exposed to light prior to the addition of a protein kinase inhibitor,
phosphorylation would already be abundant, and therefore, inhibition of translation would
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not be observed.

If~

however, the Volvox were kept in the dark until the addition of the

protein kinase inhibitor, and only then were exposed to the light, phosphorylation would
not occur (or only minimal phosphorylation would occur, depending on the time needed for
the drug to permeate the membrane and to reach full inhibitory capacity), and the result
would be inhibition of protein synthesis. Indeed, this is what we have observed in this
study.
By compiling these three concurring analyses, we have come up with the model
depicted in figure 10. The presence of light suppresses the cytosolic level of cOMP which
thereby reduces the activity of a cOMP-dependent phosphatase and increases
phosphorylation of some component required for active translation. Conversely, in the
dark, abundant cGMP results in increased phosphatase activity and reduced
phosphorylation. Necessary enzymes for translation cannot be activated, and protein
synthesis does not occur.

DARK:
Active
High [cGMP] ...... cGMP-dependent phosphatase ~ ~ ,Translation
LIGHT:
Inactive
Low [cGMP] ...... cGMP-dependent phosphatase ~ ~ Translation
Figure 10. A possible model for cGMP-dependent translational control in
Volvox carteri relying on a cGMP-dependent phosphatase.
The model shown in figure 10 is not the only possibility for a signal transduction
pathway that agrees with our observations. Another possibility is a model that directly
involves a common regulatory component in signal transduction pathways. the G-protein
(figure 11). The absence of light would cause the photoreceptor to activate a stimulatory
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G-protein which would activate guanylate cyclase. resulting in high [cGMP]. Abundant
cGMP, acting as a second messenger may react with another intracellular component, and
cause dOWDstre3m phosphorylation/dephosphorylation events that eventually lead to
translation. In contrast, in the presence of light, the inhibitory G-protein would be
activated, thus yielding low intracellular concentrations of cGMP, and by a similar cascade
of events, inhibiting protein synthesis.

LIGHT---. Inhibitory G-protein

~Low cG~ --+

DARK ....... Stimulatory G-protein ---.High cGl\1P ~

Translation

~ Translation

Figure 11. Another possible model for cGMP-dependent translational
control in Volvox cQrteri, based on G-protein regulation.

In order to address certain discrepancies which appeared in the results, it will be
helpful to consider the nature of many of the drugs utilized in this study. First, aU of these
drugs were characterized in systems other than algae, and while it is known that certain
elements such as protein kinases, phosphatases, phosphodiesterases, and cyclic nucleases,
among others, do exist wilhin Volvox carteri. it has not been proven that they play the same
roles in algal systems as they do in the systems in which they were characterized One
must also consider the permeability of these drugs to both the cell wall and the plasma
membrane of Volvox carten, because if the drugs are never entering the cell, no
intracellular changes would be detected. The fact that the drugs may not be acting on the

Volvox in the expected manner (table 1) or the fact that the drugs may not be entering the
cells, could both explain the lack of any changes in translation in experiments using many
of the drugs. Another explanation for the lack of effectiveness of the drugs could be in the
specificity of the drugs to enzymes which are not important in the relay between light and
protein synthesis. For example, though we might postulate that a phosphataSe inhibitor
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(like okadaic acid) should have some capacity to

acti~ate

protein synthesis. especially in

the model in which Volvox are exposed to light prior to drug addition, and then kept in the
dark, we know that okadaic acid is specific for only protein phosphatases 1 and 2A, but
does not affect any acid, alkaline, or tyrosine phosphatases (CALBIOCHEM~, 1996/97).
(Unpublished results, however, suggest that tyrosine pbosphatases are not involved in the
regulation of protein synthesis in Volvox (Jovanovic, 1996»). In addition, LY83583 is
described as an inhibitor of soluble guanylate cyclase (CALBIOCHE~, 1996/97), but it is
possible that if guanylate cyclase is important in this signal transduction pathway, it is a
membrane bound protein which remains unaffected, or only minimally affected by
LY83583. There could be other incidences of similar alterations in foans of the targeted
protein that result in the ineffectiveness of a specific drug. Finally, many of these drugs
have multiple effects. LY83583 is again a perfect example of this potential complication
since not only is it known to inhibit the activity of soluble guanylate cyclase, but it is also a
known inhibitor of certain nitric oxide effects (such as smooth muscle relaxation) and
certain interleukin-l induced effects (such as cGMP accumulation in aortic vascular cells) in
rats (CALBI~, 1996/97). SQ22536 is also known

(0

have multiple effects

including an enhancement of oxygen radical production (CALBI~, 1996/97). We
have therefore attributed the high degree of variability in the results of our experiments with
LY83583 to the multiple effects of this drug.
Examining intracellular cGMP concentrations has provided evidence which
suppons both of the above models in which high levels of cGMP induce low levels of
prolein synthesis and low levels of cGMP yield high levels of protein synthesis. As
expected we found increasing amounts of cGMP with time spen( in the dark, however, we
expecled a plot of this data to produce a predictable trendline such as a rectangular
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hyperbola We are currently in the process of repeating these experiments to determine
whether or not this data is reproducible.
Further studies chat should be done to further examine this model include obtaining
mutants to drugs which are capable of inhibiting protein synthesis. The availability of
mutants would permit useful genetic and molecular anaJyses of the necessary components

in this putative signal transduction pathway. In addition, identifying a cGMP-dependent
protein phosphatase which is more active in the dark than in the light would give supportive
evidence to figure 10. Studies such as these are currently underway in our lalx>ratory.
Once this portion of the pathway is understood, a more directed progression towards the
targets of phosphorylation will be possible, as well as regression towards the photoreceptor
end of the pathway, including identification of inhibitory and stimulatory G-proteins, as
well as qualification of any light-dependent activities of these proteins which would provide
suppon for figure 11. By obtaining and compiling this type of infonnation. we hope to
develop a complete picture of the light-dependent signal transduction pathway which
controls translation in Volvox carten.
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